Chemoinformaics analysis of 4-O-Methylepisappanol
| Molecular Weight | 318.325 | nRot | 3 |
| Heavy Atom Molecular Weight | 300.181 | nRig | 17 |
| Exact Molecular Weight | 318.11 | nRing | 3 |
| Solubility: LogS | -3.121 | nHRing | 1 |
| Solubility: LogP | 1.758 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 45.2043 |
| nHD | 4 | BPOL | 21.5297 |
| QED | 0.645 |
| Synth | 3.572 |
| Natural Product Likeliness | 2.045 |
| NR-PPAR-gamma | 0.39 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.518 |
| HIA | 0.228 |
| CACO-2 | -5.092 |
| MDCK | 0.00000733 |
| BBB | 0.025 |
| PPB | 0.956839 |
| VDSS | 0.703 |
| FU | 0.0475664 |
| CYP1A2-inh | 0.437 |
| CYP1A2-sub | 0.549 |
| CYP2c19-inh | 0.104 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.389 |
| CYP2c9-sub | 0.84 |
| CYP2d6-inh | 0.494 |
| CYP2d6-sub | 0.79 |
| CYP3a4-inh | 0.649 |
| CYP3a4-sub | 0.328 |
| CL | 15.016 |
| T12 | 0.902 |
| hERG | 0.059 |
| Ames | 0.771 |
| ROA | 0.21 |
| SkinSen | 0.94 |
| Carcinogencity | 0.073 |
| EI | 0.893 |
| Respiratory | 0.223 |
| NR-Aromatase | 0.871 |
| Antiviral | Yes |
| Prediction | 0.776552 |